Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 7Phase 1 6Phase 1/2 4

Status

Active not recruiting 4Recruiting 3

Sponsor Class

INDUSTRY 6OTHER 1

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 7Genitourinary 3

Conditions

Breast Neoplasms 5Locally Advanced (Inoperable) or Metastatic Breast Cancer 2Disease Progression 2Triple Negative Breast Neoplasms 1Neoplasm Metastasis 1

Interventions

Cyclophosphamide 171Docetaxel 164Paclitaxel 160Trastuzumab 152Capecitabine 130Tamoxifen 119Letrozole 105Epirubicin 93Doxorubicin 83Anastrozole 83exemestane 77Fulvestrant 75Carboplatin 64Fluorouracil 63Radiotherapy 61pertuzumab 59Gemcitabine 55Vinorelbine 43Goserelin 39eribulin 36130-nm albumin-bound paclitaxel 36palbociclib 32Bevacizumab 32ribociclib 30Zoledronic Acid 29Lapatinib 29Methotrexate 28Drug Therapy 28Chemotherapy, Adjuvant 28Ado-Trastuzumab Emtansine 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × capivasertib × Breast × Clear all
NCT04862663 2026-05-27

CAPItello-292

AstraZeneca

Phase 3 Recruiting
895 enrolled
Breast

Locally Advanced (Inoperable) or Metastatic Breast Cancer

NCT06982521 2026-05-08

ReDiscover-2

Relay Therapeutics, Inc.

Phase 3 Recruiting
540 enrolled
Breast

Breast Neoplasms

NCT04305496 2026-04-30

CAPItello-291

AstraZeneca

Phase 3 Active not recruiting
818 enrolled 19 charts 2 FDA
Breast

Locally Advanced (Inoperable) or Metastatic Breast Cancer

NCT06764186 2026-04-08

CAPItana

AstraZeneca

Phase 3 Active not recruiting
101 enrolled
Breast

Breast Neoplasms

NCT06635447 2026-03-27

CAPItrue

AstraZeneca

Phase 3 Active not recruiting
258 enrolled
Breast

Breast Neoplasms, Disease Progression

NCT07281833 2026-02-27

CAPIcorn

West German Study Group

Phase 3 Recruiting
250 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Disease Progression

NCT03997123 2025-12-22

CAPItello-290

AstraZeneca

Phase 3 Active not recruiting
923 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡